Paracelsus Medical University Salzburg and Boehringer Ingelheim Collaborate to Explore Regenerative Potential of Extracellular Vesicles (EVs)

Paracelsus Medical University (PMU) is proud to announce, on September 19, 2022, the beginning of a research collaboration with Boehringer Ingelheim. This collaboration aims to investigate the natural regenerative potential of stromal cell-derived extracellular vesicle (EVs) in disorders with high medical need that affect musculoskeletal tissues and the central nervous system. Planned preclinical studies will utilize the unique EV preparations that are manufactured according to Good Manufacturing Practice (GMP) at PMU's Spinal Cord Injury and Tissue Regeneration Center Salzburg (SCI-TReCS). The collaboration is enabled by Boehringer Ingelheim through its Research Beyond Borders program and is part of the company’s long-term commitment to explore emerging and innovative technologies.

Login Or Register To Read Full Story